Ruxience and Inflammation - a phase IV clinical study of FDA data

Summary:

Inflammation is reported as a side effect among people who take Ruxience (rituximab-pvvr), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Inflammation when taking Ruxience. It is created by eHealthMe based on reports of 4,258 people who have side effects when taking Ruxience from the FDA, and is updated regularly.

What is Ruxience?

Ruxience has active ingredients of rituximab-pvvr. eHealthMe is studying from 4,260 Ruxience users. Check the latest studies of Ruxience.

What is Inflammation?

Inflammation is found to be associated with 1,709 drugs and 1,873 conditions by eHealthMe. Check the latest studies of Inflammation.

On Jul, 19, 2026

4,258 people reported to have side effects when taking Ruxience.
Among them, 62 people (1.46%) have Inflammation.

Among these 62 people:

How long have people been on Ruxience when they have Inflammation? *

What is the gender of people who have Inflammation when taking Ruxience? *

female: 87.1 %
male: 12.9 %

What is the age of people who have Inflammation when taking Ruxience? *

What are other drugs people take besides Ruxience? *

What are other side effects people have besides Inflammation? *

Rashes (redness): 18 people, 29.03%
Joint Pain: 16 people, 25.81%
C-Reactive Protein Increased: 15 people, 24.19%
Weakness: 14 people, 22.58%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 13 people, 20.97%
Pain: 13 people, 20.97%
Dyspnea (difficult or laboured breathing): 11 people, 17.74%
Heart Rate Increased: 10 people, 16.13%
Nausea (feeling of having an urge to vomit): 10 people, 16.13%
Malaise (a feeling of general discomfort or uneasiness): 9 people, 14.52%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 24 people, 38.71%
Microscopic Polyangiitis (inflammation involving multiple blood or lymph small-vessel): 13 people, 20.97%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 6 people, 9.68%
Behcet's Syndrome (involves inflammation of the blood vessels): 4 people, 6.45%
Vasculitis (inflammation of a blood vessel or blood vessels): 3 people, 4.84%
Pulmonary Vasculitis: 2 people, 3.23%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 3.23%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 2 people, 3.23%
Pain In Extremity: 1 person, 1.61%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 1 person, 1.61%

* Approximation only. Some reports may have incomplete information.

Do you take Ruxience and have Inflammation?

- Check whether Inflammation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ruxience:

Ruxience (4,260 reports)

Inflammation treatments and more:

Inflammation (78,906 reports)

Browse all side effects of Ruxience:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Inflammation:

Inflammation (1,710 drugs)

Browse all the conditions that are associated with Inflammation:

Inflammation (1,873 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rituximab-pvvr (the active ingredients of Ruxience) and Ruxience (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.